{"transactions":[{"id":3988794,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2018-03-19T17:12:44.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":19112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under Issuer's 2013 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022."}],"balance_after":19112,"derivative":{"exercise_price":13.24,"expiration_date":"2028-03-15","underlying":"Ordinary Shares","underlying_shares":19112},"source":{"system":"sec-edgar","filing":"0001437749-18-004971","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586049/000143774918004971/rdgdoc.xml","form_type":"4"}},{"id":3988793,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-19T17:12:44.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":4370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22992,"source":{"system":"sec-edgar","filing":"0001437749-18-004971","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586049/000143774918004971/rdgdoc.xml","form_type":"4"}},{"id":4250711,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2017-07-26T16:30:46.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":61920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Option granted under Issuer's 2013 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options will become exercisable ratably on the anniversary of the vesting start date from August 1, 2018 through August 1, 2021."}],"balance_after":61920,"derivative":{"exercise_price":16.11,"expiration_date":"2027-07-24","underlying":"Ordinary Shares","underlying_shares":61920},"source":{"system":"sec-edgar","filing":"0001437749-17-013099","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586049/000143774917013099/rdgdoc.xml","form_type":"4"}},{"id":4250710,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2017-07-26T16:30:46.000Z","date":"2017-07-24","kind":"grant","acquired":true,"shares":18622,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18622,"source":{"system":"sec-edgar","filing":"0001437749-17-013099","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586049/000143774917013099/rdgdoc.xml","form_type":"4"}},{"id":4590906,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-10-03T21:50:14.000Z","date":"2016-09-30","kind":"disposition_to_issuer","acquired":false,"shares":931,"price":20.58,"value":19159.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":50207,"source":{"system":"sec-edgar","filing":"0001645683-16-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000164568316000012/edgardoc.xml","form_type":"4"}},{"id":4599372,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-20T13:03:32.000Z","date":"2016-09-17","kind":"disposition_to_issuer","acquired":false,"shares":931,"price":20.92,"value":19476.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":51138,"source":{"system":"sec-edgar","filing":"0001645683-16-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000164568316000010/edgardoc.xml","form_type":"4"}},{"id":4602003,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":168190,"kind":"person","name":"Wenstrup Richard","position":1,"cik":"0001645683","reported_name":"Wenstrup Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-09-16T18:04:43.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020."}],"balance_after":52069,"source":{"system":"sec-edgar","filing":"0001645683-16-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000164568316000008/edgardoc.xml","form_type":"4"}}]}